P V Browne
Overview
Explore the profile of P V Browne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bright S, Byrne A, Vandenberghe E, Browne P, Mcelligott A, Meegan M, et al.
Oncol Rep
. 2019 Mar;
41(5):3127-3136.
PMID: 30896840
The nitrostyrene scaffold was previously identified as a lead target structure for the development of effective compounds targeting Burkitt's lymphoma. The present study aimed to develop these compounds further in...
2.
OConnell N, Martin-Hernandez M, Chacko J, Duggan C, OBriain D, Moriarty J, et al.
Hematology
. 2016 Jul;
6(1):65-8.
PMID: 27419606
Thrombotic thrombocytopenic purpura (TTP) is a systemic disease characterised by the presence of microvascular thrombi resulting from endothelial injury and platelet activation. Vascular occlusion leads to the clinical manifestations of...
3.
Lavin M, Brophy T, Rawley O, OSullivan J, Hayden P, Browne P, et al.
J Thromb Haemost
. 2016 Mar;
14(6):1200-5.
PMID: 26991062
Unlabelled: Essentials Treatment options are limited for refractory bleeding in acquired von Willebrand Syndrome (AVWS). Lenalidomide therapy was studied in two patients with AVWS due to monoclonal gammopathy (MG). Lenalidomide...
4.
OKane G, Bracken-Clarke D, Gardiner N, Lee G, Chonghaile M, Power D, et al.
Bone Marrow Transplant
. 2016 Feb;
51(6):856-9.
PMID: 26855151
No abstract available.
5.
Smyth L, Browne P, Conneally E, Flynn C, Hayden P, Jeffers M, et al.
Ir J Med Sci
. 2015 Apr;
185(4):773-777.
PMID: 25843016
Background: Sporadic Burkitt lymphoma (BL), characterised by translocation-associated C-MYC upregulation is a rare, aggressive lymphoma with a cure rate up to 90 % using the R-CODOX-M/R-IVAC (RCRI) protocol. RCRI is...
6.
Fahy C, Fortune A, Quinn F, McMenamin M, Browne P, Langabeer S, et al.
Br J Dermatol
. 2013 Oct;
170(2):462-7.
PMID: 24116988
We report on a patient who developed donor-derived cutaneous T-cell lymphoma (CTCL) 4 years after successful treatment of chronic myeloid leukaemia with an allogeneic bone marrow transplant. The patient developed...
7.
Langabeer S, OBrien D, Liptrot S, Flynn C, Hayden P, Conneally E, et al.
Int J Lab Hematol
. 2012 Feb;
34(4):417-21.
PMID: 22313586
Hairy cell leukaemia (HCL) has distinct clinical, morphological and immunophenotypic features with no recurrent cytogenetic or molecular abnormalities reported until the recent description of the BRAF V600E mutation in patients...
8.
Maginn E, Browne P, Hayden P, Vandenberghe E, MacDonagh B, Evans P, et al.
Br J Cancer
. 2010 Dec;
104(2):281-9.
PMID: 21179037
Background: In recent years, much progress has been made in the treatment of multiple myeloma. However, a major limitation of existing chemotherapeutic drugs is the eventual emergence of resistance; hence,...
9.
Bacon C, Daly P, Sheane B, Conneally E, Browne P, McCann S, et al.
Ir Med J
. 2009 Mar;
102(1):26-8.
PMID: 19284016
Patients with Hodgkin lymphoma who relapse or are refractory to first line multi-agent chemotherapy can be successfully salvaged with high dose therapy (HDT) and autologous stem cell transplant (ASCT). Twenty-six...
10.
ODonghaile D, Hayden P, McCarron S, Doyle E, Lawler M, Browne P, et al.
Eur J Haematol
. 2006 Feb;
76(3):258-60.
PMID: 16451399
Secondary or late graft failure has been defined as the development of inadequate marrow function after initial engraftment has been achieved. We describe a case of profound marrow aplasia occurring...